Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma

Cancer Biology and Therapy

Volumn 12, Issue 4, 2011, Pages 304-313

  Yu, Chuigong ^a   Wu, Guojun ^a   Dang, Nana ^a   Zhang, Wei ^a   Zhang, Rui ^a   Yan, Wei ^a   Zhao, Yi ^a   Gao, Lei ^a   Wang, Yingmei ^a   Beckwith, Noor ^b   Yuan, Jianlin ^a   Yao, Libo ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Adenovirus; c Myc; Carcinogenesis; Gene therapy; Inhibition; NDRG2; Prostatic carcinoma

Indexed keywords

MYC PROTEIN; N MYC DOWNSTREAM REGULATED GENE 2 PROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL GROWTH; CONTROLLED STUDY; FLOW CYTOMETRY; GLEASON SCORE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT;

ADENOVIRIDAE; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM TRANSPLANTATION; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

EID: 84860388807     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.4.16382     Document Type: Article

References (18)

1. Rubin M.A. Targeted therapy of cancer: New roles for pathologists- prostate cancer. Mod Pathol 2008; 21:44-55.
2. Shimono A., Okuda T., Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 1999; 83:39-52. (Pubitemid 29302080)
3. Zhou R.H., Kokame K., Tsukamoto Y., Yutani C., Kato H., Miyata T. Characterization of the human NDRG gene family: A newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 2001; 73:86-97. (Pubitemid 32382390)
4. Deng Y., Yao L., Chau L., Ng S.S., Peng Y., Liu X., et al. N-myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 2003; 106:342-347 (Pubitemid 36870394)
5. Deng Y.C., Wang J.C., Liu X.P., Ji S.P., Yao L.B. Cloning tumor-related genes and tumor suppressor genes in glioma with polymerase chain reaction-based subtractive hybridization. Ai Zheng 2005; 24:680-684
6. Piepoli A., Cotugno R., Merla G., Gentile A., Augello B., Quitadamo M., et al. Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumor. BMC Med Genomics 2009; 2:11-15
7. Zhao H., Zhang J., Lu J., He X., Chen C., Li X., et al. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer. BMC Cancer 2008; 8:303-311
8. Tepel M., Roerig P., Wolter M., Gutmann D.H., Perry A., Reifenberger G., et al. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. Int J Cancer 2008; 123:2080-2086
9. Ma J., Jin H., Wang H., Yuan J., Bao T., Jiang X., et al. Expression of NDRG2 in clear cell renal cell carcinoma. Biol Pharm Bull 2008; 31:1316-1320 (Pubitemid 351930639)
10. Park Y., Shon S.K., Kim A., Kim K.I., Yang Y., Cho D.H., et al. SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochem Biophys Res Commun 2007; 363:361-367 (Pubitemid 47484341)
11. Foletta V.C., Prior M.J., Stupka N., Carey K., Segal D.H., Jones S., et al. NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors. J Physiol 2009; 587:1619-1634
12. Choi S.C., Kim K.D., Kim J.T., Kim J.W., Yoon D.Y., Choe Y.K., et al. Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett 2003; 553:413-418 (Pubitemid 37315641)
13. Aggarwal R., Ryan C.J. Castration-resistant prostate cancer: Targeted therapies and individualized treatment. Oncologist 2011; 16:264-275
14. Bracarda S., Logothetis C., Sternberg C.N., Oudard S. Current and emerging treatment modalities for metastatic castration-resistant prostate cancer. BJU Int 2011; 107:13-20.
15. Yao L., Zhang J., Liu X. NDRG2: A Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin (Shanghai) 2008; 40:625-635 (Pubitemid 352009078)
16. Liu N., Wang L., Li X., Yang Q., Liu X., Zhang J., et al. N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis. Nucleic Acids Res 2008; 36:5335-5349
17. Zhang J., Li F., Liu X., Shen L., Liu J., Su J., et al. The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J Bio Chem 2006; 281:39159-39168 (Pubitemid 46041876)
18. Yang G., Timme T.L., Frolov A., Wheeler T.M., Thompson T.C. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Cancer 2005; 103:1186-1194 (Pubitemid 40328089)